Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy.
Edward R. O’Brien(Libin Cardiovascular Institute of Alberta), Stephen M. Schwartz(University of Washington), Charles E. Alpers(University of Washington), Earl P. Benditt(University of Washington), Marina S. Ferguson(University of Washington), Nam T. Tran(University of Washington), David Gordon(Universidade Federal de Ouro Preto), Tomoaki Hinohara(Keio University), Douglas K. Stewart(University of Washington), John B. Simpson(Southern General Hospital)
Cited by 365
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
<i>Consed:</i> A Graphical Tool for Sequence Finishing
|Genome Research|1998|3.3k
The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited
|Journal of the American Society of Nephrology|2004|2k
A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women
|New England Journal of Medicine|2005|2k
The classification of glomerulonephritis in systemic lupus erythematosus revisited
|Kidney International|2004|1.7k